JPWO2025023312A1 - - Google Patents

Info

Publication number
JPWO2025023312A1
JPWO2025023312A1 JP2025502805A JP2025502805A JPWO2025023312A1 JP WO2025023312 A1 JPWO2025023312 A1 JP WO2025023312A1 JP 2025502805 A JP2025502805 A JP 2025502805A JP 2025502805 A JP2025502805 A JP 2025502805A JP WO2025023312 A1 JPWO2025023312 A1 JP WO2025023312A1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2025502805A
Other languages
Japanese (ja)
Other versions
JPWO2025023312A5 (https=
JP7725041B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of JPWO2025023312A1 publication Critical patent/JPWO2025023312A1/ja
Publication of JPWO2025023312A5 publication Critical patent/JPWO2025023312A5/ja
Application granted granted Critical
Publication of JP7725041B2 publication Critical patent/JP7725041B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M1/00—Apparatus for enzymology or microbiology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M3/00—Tissue, human, animal or plant cell, or virus culture apparatus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Sustainable Development (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Plant Pathology (AREA)
  • Inorganic Chemistry (AREA)
  • Peptides Or Proteins (AREA)
JP2025502805A 2023-07-26 2024-07-25 コラーゲン結合型膜透過性ペプチド、並びに、該ペプチド及びコラーゲン若しくはコラーゲン誘導体を含む運搬体 Active JP7725041B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2023121675 2023-07-26
JP2023121675 2023-07-26
PCT/JP2024/026723 WO2025023312A1 (ja) 2023-07-26 2024-07-25 コラーゲン結合型膜透過性ペプチド、並びに、該ペプチド及びコラーゲン若しくはコラーゲン誘導体を含む運搬体

Publications (3)

Publication Number Publication Date
JPWO2025023312A1 true JPWO2025023312A1 (https=) 2025-01-30
JPWO2025023312A5 JPWO2025023312A5 (https=) 2025-07-01
JP7725041B2 JP7725041B2 (ja) 2025-08-19

Family

ID=94375490

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025502805A Active JP7725041B2 (ja) 2023-07-26 2024-07-25 コラーゲン結合型膜透過性ペプチド、並びに、該ペプチド及びコラーゲン若しくはコラーゲン誘導体を含む運搬体

Country Status (2)

Country Link
JP (1) JP7725041B2 (https=)
WO (1) WO2025023312A1 (https=)

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008067717A (ja) * 2001-06-20 2008-03-27 Dainippon Sumitomo Pharma Co Ltd 核酸導入を促進させる方法
JP2014210730A (ja) * 2013-04-18 2014-11-13 株式会社高研 細胞膜透過性ペプチドを付加したコラーゲン又はコラーゲン誘導体を含む運搬体
WO2016068228A1 (ja) * 2014-10-29 2016-05-06 株式会社高研 薬剤徐放担体及び薬剤徐放方法
WO2016199674A1 (ja) * 2015-06-11 2016-12-15 学校法人慶應義塾 融合タンパク質又は複合タンパク質、細胞内送達用担体、部分ペプチド、細胞膜透過促進剤、ｄｎａ、及びベクター
JP2019534922A (ja) * 2016-10-04 2019-12-05 コーネル ユニヴァーシティー 潤滑性ブロックコポリマーおよび生体模倣境界潤滑剤としてのそれらの使用
JP2020526493A (ja) * 2017-07-07 2020-08-31 サイミック アイピー， エルエルシー 化学的に修飾された主鎖を有するバイオコンジュゲート
WO2022125673A1 (en) * 2020-12-09 2022-06-16 Fred Hutchinson Cancer Research Center Cell-penetrating peptides and peptide complexes and methods of use
WO2023090381A1 (ja) * 2021-11-18 2023-05-25 ピューロテックバイオ株式会社 宿主因子ｄｏｃｋ１１をターゲットとした抗ｂ型肝炎ウイルス剤

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008067717A (ja) * 2001-06-20 2008-03-27 Dainippon Sumitomo Pharma Co Ltd 核酸導入を促進させる方法
JP2014210730A (ja) * 2013-04-18 2014-11-13 株式会社高研 細胞膜透過性ペプチドを付加したコラーゲン又はコラーゲン誘導体を含む運搬体
WO2016068228A1 (ja) * 2014-10-29 2016-05-06 株式会社高研 薬剤徐放担体及び薬剤徐放方法
WO2016199674A1 (ja) * 2015-06-11 2016-12-15 学校法人慶應義塾 融合タンパク質又は複合タンパク質、細胞内送達用担体、部分ペプチド、細胞膜透過促進剤、ｄｎａ、及びベクター
JP2019534922A (ja) * 2016-10-04 2019-12-05 コーネル ユニヴァーシティー 潤滑性ブロックコポリマーおよび生体模倣境界潤滑剤としてのそれらの使用
JP2020526493A (ja) * 2017-07-07 2020-08-31 サイミック アイピー， エルエルシー 化学的に修飾された主鎖を有するバイオコンジュゲート
WO2022125673A1 (en) * 2020-12-09 2022-06-16 Fred Hutchinson Cancer Research Center Cell-penetrating peptides and peptide complexes and methods of use
WO2023090381A1 (ja) * 2021-11-18 2023-05-25 ピューロテックバイオ株式会社 宿主因子ｄｏｃｋ１１をターゲットとした抗ｂ型肝炎ウイルス剤

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
田苗見 綾 他: "アテロコラーゲン結合型膜透過性ペプチドの開発とそのメカニズム解析", 第３６回日本ＤＤＳ学会学術集会プログラム予稿集, vol. Ｐ−６５, JPN6024034072, 10 August 2020 (2020-08-10), ISSN: 0005585443 *
藤本 一朗 他: "核酸デリバリーにおけるアテロコラーゲンと種々の機能性ペプチドのメカニズム解析", 第３７回日本ＤＤＳ学会学術集会プログラム予稿集, vol. Ｐ−１３３, JPN6024034074, 7 June 2021 (2021-06-07), ISSN: 0005585444 *

Also Published As

Publication number Publication date
WO2025023312A1 (ja) 2025-01-30
JP7725041B2 (ja) 2025-08-19

Similar Documents

Publication Publication Date Title
BR102022025291A2 (https=)
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001987A2 (https=)
BR102023001877A2 (https=)
BR102023000289A2 (https=)
BR102022026909A2 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
BY13141U (https=)
BY13151U (https=)
BY13135U (https=)
BY13136U (https=)
BY13137U (https=)
BY13138U (https=)
BY13139U (https=)
BY13140U (https=)
CN307045532S (https=)

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250325

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250325

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20250325

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250501

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250627

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20250707

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250711

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20250711

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20250729

R150 Certificate of patent or registration of utility model

Ref document number: 7725041

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150